Nuvation Bio Inc.: Citigroup initiates coverage with buy rating; target price $12
NUVB•Citigroup initiated coverage of Nuvation Bio with a buy rating and a $12 target price.
Related News
Erock Inc coverage initiated with buy rating and $24 price target
EROC•
Hormel Foods agrees to buy Brakebush Brothers for $1.055 billion
HRL•
EM stocks set for quarterly losses; Turkey selloff deepens
EEM•
Sterling at strongest in over a month versus euro after GDP revision reinforces BoE hike bets
EWU•
Tandem Diabetes Care: Citigroup cuts target price to $20 from $24
TNDM•